Skip to Content

R 626 (Zafirlukast 20 mg)

Pill imprint R 626 has been identified as Zafirlukast 20 mg.

Zafirlukast is used in the treatment of asthma, maintenance and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Zafirlukast 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Zafirlukast 20 mg R 626
Zafirlukast
Imprint:
R
626
Strength:
20 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0626
Inactive Ingredients:
hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide